PanOptica secures $45 million in series B

Ophthalmology play PanOptica Inc. (Mount Arlington, N.J.) secured $45 million in a tranched series B round co-led by new investor Novo Ventures and existing investor Third Rock Ventures. Existing investor SV Life Sciences also participated. PanOptica said the tranches are tied to milestones related to PAN-90806, but declined to disclose details, including how much the company raised in the first tranche. Novo's Thomas Dyrberg will join PanOptica's board. ...